These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9749317)

  • 1. [Inactivation and stabilization of urokinase fibrinolytic activity in vitro].
    Aĭsina RB; Mukhametova LI; Sazonova IIu; Varfolomeev SD
    Bioorg Khim; 1998 Jul; 24(7):544-8. PubMed ID: 9749317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of a novel fibrinolytic enzyme from Streptomyces spp.
    Wang J; Wang M; Wang Y
    Chin J Biotechnol; 1999; 15(2):83-9. PubMed ID: 10719627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective fibrinolytic activity of recombinant non-glycosylated human pro-urokinase (single-chain urokinase-type plasminogen activator) from bacteria.
    Hanbücken FW; Schneider J; Günzler WA; Friderichs E; Giertz H; Flohé L
    Arzneimittelforschung; 1987 Aug; 37(8):993-7. PubMed ID: 3118890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UFEIII, a fibrinolytic protease from the marine invertebrate, Urechis unicinctus.
    Bi Q; Han B; Liu W; Feng Y; Jiang Z
    Biotechnol Lett; 2013 Jul; 35(7):1115-20. PubMed ID: 23515896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A hybrid molecule of pro-urokinase and a fibrin-specific, monoclonal antibody fragment is a more effective thrombolytic agent than pro-urokinase in vitro and in vivo].
    Bode C; Eberle T; Runge M; Haber E; Kübler W
    Verh Dtsch Ges Inn Med; 1990; 96():1-3. PubMed ID: 2128723
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinolytic activity of immobilized plasminogen activator.
    Senatore FF; Bernath FR
    Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):295-304. PubMed ID: 4059655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An enhancing effect of poly-lysine on the activation of plasminogen.
    Allen RA
    Thromb Haemost; 1982 Feb; 47(1):41-5. PubMed ID: 7200268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional properties of a recombinant chimeric plasminogen activator with platelet-targeted fibrinolytic and anticoagulant potential.
    Zhang L; Wang J; Yu M; Ru B
    Mol Genet Metab; 2004 Aug; 82(4):304-11. PubMed ID: 15308128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative ex vivo study of plasminogen activators and proteases for fibrinolytic activity and side effects in rabbits.
    Janik BA; Papaioannou SE
    Thromb Haemost; 1977 Feb; 37(1):154-61. PubMed ID: 576512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
    Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and some properties of urokinase.
    Ogawa N; Yamamoto H; Katamine T; Tajima H
    Thromb Diath Haemorrh; 1975 Sep; 34(1):194-209. PubMed ID: 242089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
    Hunt JA; Petteway SR; Scuderi P; Novokhatny V
    Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel thermostable nitrilase superfamily amidase from Geobacillus pallidus showing acyl transfer activity.
    Makhongela HS; Glowacka AE; Agarkar VB; Sewell BT; Weber B; Cameron RA; Cowan DA; Burton SG
    Appl Microbiol Biotechnol; 2007 Jun; 75(4):801-11. PubMed ID: 17347819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XIIa is a kinetically favorable plasminogen activator.
    Schousboe I; Feddersen K; Røjkjaer R
    Thromb Haemost; 1999 Sep; 82(3):1041-6. PubMed ID: 10494761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterization of urokinase type plasminogen activator modified by phenylglyoxal].
    Mukhametova LI; Aĭsina RB; Lomakina GIu; Varfolomeev SD
    Bioorg Khim; 2002; 28(4):308-14. PubMed ID: 12197387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of a disulfide-linked bioconjugate of annexin V with the B-chain of urokinase: an improved fibrinolytic agent targeted to phospholipid-containing thrombi.
    Tanaka K; Einaga K; Tsuchiyama H; Tait JF; Fujikawa K
    Biochemistry; 1996 Jan; 35(3):922-9. PubMed ID: 8547274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic agents.
    Schmitz-Huebner U; van de Loo J
    Clin Haematol; 1981 Jun; 10(2):481-96. PubMed ID: 7032785
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
    Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC
    Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physico-chemical properties of the thrombolytic compound longolytin].
    Tsymanovich SA; Nikandrov VN; Maksimova RA; Sharkova TS; Andreenko GV; Serebriakova TN
    Vopr Med Khim; 1992; 38(3):44-5. PubMed ID: 1413650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.